Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma
Explore this paper's citation graph
Summary
The objective of the current study was to determine the optimal radiotherapy utilization rate for patients with head and neck carcinoma and to compare this optimal rate with actual utilization rates where actual utilization data were available.
- Type
- review
- Published
- 2005-06-01
- Cited by
- 48
- References
- 83
- Access
- Open access
- OpenAlex
- https://openalex.org/W2021414173
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8438788
Keywords
Medicine, Radiation therapy, Carcinoma, Head and neck cancer, Larynx
References
- Carcinoma of the nasopharynx. Review of 146 patients with emphasis on radiation dose and time factors.
- Radiotherapy utilization in New South Wales from 1996 to 1998.
- Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma
- Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial.
- Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer.
- Surgical treatment of early oral carcinoma—Results of a prospective controlled multicenter study
- Rules of evidence and clinical recommendations on the use of antithrombotic agents.
- Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
- How do we bring an acceptable level of radiotherapy services to a dispersed population?
- Carcinoma of major salivary glands
- Carcinoma of the nasopharynx.
- An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer.
- Resources and productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987.
- Initial treatment of the early stages (I, II) of supraglottic squamous cell carcinoma: partial laryngectomy versus radiotherapy
- Review of the Evidence.
- THE TREATMENT OF CHOLERA
- Outcome Analysis for Lip Carcinoma
- Malignant salivary tumors--analysis of prognostic factors and survival.
- A model for decision making for the use of radiotherapy in lung cancer.
Cited by
- Organ preservation protocols in developing countries
- Laryngeal cancer treatment and survival differences across regional cancer centres in Ontario, Canada.
- The role of radiotherapy in cancer treatment
- What is access to radiation therapy? A conceptual framework and review of influencing factors.
- Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012.
- The population benefit of radiotherapy for cervical cancer: local control and survival estimates for optimally utilized radiotherapy and chemoradiation.
- Estimating the population benefit of radiotherapy: using demand models to estimate achievable cancer outcomes.
- Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: a systematic review.
- Utilization of radiation therapy in Norway after the implementation of the national cancer plan--a national, population-based study.
- Reirradiation for recurrent head and neck cancer
- Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence‐based clinical guidelines
- Establishing treatment benchmarks for mammography‐screened breast cancer population based on a review of evidence‐based clinical guidelines
- IMRT and IGRT in head and neck cancer: Have we delivered what we promised?
- Hidden danger, obvious opportunity: error and risk in the management of cancer.
- Monte Carlo applications for local treatment healthcare usage simulations
- Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: setting an evidence-based benchmark for the best-quality cancer care.
- mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis
- The population benefit of radiotherapy for gynaecological cancer: Local control and survival estimates.
- Patient engagement in radiation therapy
- Barriers to radiotherapy utilization: Consumer perceptions of issues influencing radiotherapy‐related decisions
Related papers
- The larynx cancer in vitro study by MRI relaxtion time of water
- Surgical anatomy of the larynx
- BENIGN TUMORS OF THE LARYNX: A STUDY OF SEVEN HUNDRED AND TWENTY-TWO CASES
- Laser treatment for larynx cancer: an overview of techniques and complications
- Treatment of 32 cases of injury in the larynx
- Les dyspnées laryngées de l'enfant
- Solitary tuberculoma of the larynx: a case report.
- Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer.